(SM) as a major target organ. Indeed the SM can be likened to active lymphoid tissue with infiltrates of T and B lymphocytes and macrophages. ' The presumed stimulating agent, i.e., antigen, has long eluded identification; viral particles have sometimes been found within affected joints2 3 and a transient or prolonged arthritis may follow viral illnesses. 3 Treatment with non-steroidal anti-inflammatory drugs (NSAIDs) alleviates symptoms and supAccepted for publication 5 June 1986. Correspondence to Dr M T Walters. Department of Rheumatology, Southampton General Hospital. Tremona Road, Southampton S09 4XY. presses humoral inflammatory mediators but probably does not influence the long term outcome of the erosive joint disease. Drugs such as gold and penicillamine are believed to have a more fundamental effect on the disease process and have thus been called 'disease modifying'. Although both these drugs improve clinical and laboratory parameters of disease activity in some patients with RA during the first six months of treatment,4 their effect on retardation of the disease process in the much longer term and their mechanism of action remain in doubt. When Areas showing a fibrinous exudate were not counted. As there was variation in biopsy specimen sizes a fixed interval between each GF counted was predetermined for each slide to limit the GFs counted to a practical number.
All sections were read by MTW without knowledge of patient identity or clinical grouping. In order to identify any variation in histopathology within the suprapatellar pouch, midline region a second sample of tissue was taken in some patients from an adjacent area of synovium within 2-3 cm of the first biopsy specimen and stained in parallel. Both biopsy specimens were then assessed for the degree of correlation of T lymphocyte infiltration on a 0-6 visual scale under low power microscopy. QUANTIFICATION There were no statistically significant differences between groups I and 2 at the beginning of the study (p>0t)5, Mann-Whitney U test). The patients in group 1 all had severe disease when expressed in terms of ESR, duration of EMS, VAPS, GS, and RAI. All patients from both groups were seropositive, and some patients from both groups had circulating immune complexes. All group 1 patients improved after six months' treatment with DMD therapy as measured by weight gain, fall in ESR, IgG, and IgM, reduction in VAPS, RAI, and improvement in GS. Group 2 patients showed no significant changes in clinical or laboratory indices, apart from an improvement in EMS, which is a subjective test. We chose patients with active synovitis of a knee joint for group 2 as it seemed preferable to select patients in whom a synovial biopsy could be most easily performed by the blind, needle method. These group 2 patients can be regarded as having only partially responded to DMD therapy. Thus we have studied two distinct groups of patients with active RA: group 1 in whom we would anticipate improvement after six months' DMD therapy and group 2 who were well established on DMD therapy and would not necessarily be expected to show further improvement during the course of the study.
Previous studies using monoclonal antibodies have shown characteristic distributions of lympho- (Figs la-c) . This fall was most marked for the T4+ subset, which consequently resulted in a fall in the T4/T8 ratio to a level similar to that for group 2 patients, who did not show significant falls in either T cell subset (Fig. ld) .
The ratio of T4/T8 cells is often quoted to reflect the proportions of these regulatory T cells present and is usually high if calculated from perivascular areas, where there is a predominance of T4+ cells.' 21 This would ignore potentially functional T8+ cells found more peripherally. We found a non-random distribution of T cell subsets in that the T8+ population was preferentially located in the areas between blood vessels of the SM, but frequently there were large numbers of T8+ cells mixed with T4+ cells surrounding blood vessels. Thus in measuring the lymphocyte subsets present, we have considered all areas of the SM, including the areas between blood vessels. The T4/T8 ratio in our patients was therefore lower than in previous reports. This may reflect more accurately the balance between these regulatory subsets and elim inates any observer bias in the counting process.
We found good consistency in the total number of T lymphocytes and T subsets infiltrating the biopsy specimens taken from adjacent areas of the suprapatellar pouch SM One of the principal aims of drug therapy in RA has been the suppression of the disease process, though the drugs which achieve this are limited in use by their toxicity. Nevertheless, well publicised controlled trials with gold, D-penicillamine, and other slow acting drugs have shown significant improvement in both clinical and laboratory parameters of disease activity which became apparent within six months.4 Trials have not continued for long enough, however, to assess accurately the effect of these drugs over more prolonged periods of several years.
We have attempted to measure the effect of DMD therapy in RA over a six month period by analysing changes in both cellular components of the inflamed synovium and expression of HLA class II antigens. Our preliminary findings indicate that these drugs suppress the inflammatory reaction in the SM during the first six months of treatment, and this is in accordance with clinical observations. Previous attempts to correlate synovial histology with the severity of disease have usually been unsuccessful.3t We have shown that in 13 paired biopsy specimens the nature of the T cell infiltrate did not significantly vary over the whole SM tissue section. Preliminary evidence, however, suggests that there may be variation of HLA class II antigen expression in adjacent lymphoid aggregates. In a follow up study we are continuing to address the question of whether there is variation in the inten sity of the inflammatory infiltrate within different regions of the RA synovium, but our results from the present study suggest that blind, needle synovial biopsy specimens taken from the same area, in a longitudinal study, may be a useful means of assessing the tissue effects of established and new therapies for rheumatoid arthritis.
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